Figure 6:

(A) Scheme depicting the use of nanoparticles carrying a gamma secretase inhibitor (GSI) to suppress Notch signaling in cancer cells. (B) Nanoparticles carrying the GSI DAPT and the drug erlotinib that were coated with both CREKA tumor-homing peptides and F3 cell-penetrating peptides reduced the growth of triple negative breast cancer tumors to a greater extent than NPs coated with either targeting agent individually. Reproduced with permission from reference ¹¹⁵ under the Creative Commons Attribution License. Copyright 2019 Xu Wan, Chaoqian Liu, Yinan Lin, Jie Fu, Guohong Lu, and Zhengmao Lu. Published by Informa UK Limited, trading as Taylor & Francis Group.